AU Patent

AU4084599A — Resveratrol inhibition of myeloperoxidase

Assigned to Oklahoma Medical Research Foundation · Expires 1999-12-06 · 26y expired

What this patent protects

Patent listed against tapinarof.

Drugs covered by this patent

tapinarof (TAPINAROF)

Patent Metadata

Patent number: AU4084599A
Jurisdiction: AU
Classification: —
Expires: 1999-12-06
Drug substance claim: No
Drug product claim: No
Assignee: Oklahoma Medical Research Foundation
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.